Head-to-Head

ABBVIE INC. vs. Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares

ABBV

ABBVIE INC.

$265.21 +0.28%

VS KNSA

Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares

$78.13 +1.15%

ABBVIE INC. (ABBV) comes out ahead, leading on 6 of 9 compared factors.

Size & Scale

ABBVKNSA
Market Cap $467.37 billion $6.03 billion
Revenue (TTM) $64.39 billion $840.85 million
Net Income (TTM) $6.32 billion $80.66 million

ABBV leads on 3 of 3 size & scale factors.

Valuation

ABBVKNSA
P/E Ratio 74.92 78.92
Price / Book -79.38 9.21
Price / Sales 7.26 7.17

ABBV leads on 2 of 3 valuation factors.

Profitability

ABBVKNSA
Net Margin 9.81% 9.59%
Return on Equity -107.29% 12.33%

ABBV and KNSA split the profitability factors evenly.

Dividend

ABBVKNSA
Dividend Yield 2.61% —
Payout Ratio 195.48 —

ABBV and KNSA split the dividend factors evenly.

Risk & Sentiment

ABBVKNSA
Short Interest 0.85% 0.02%

KNSA leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABBV overview, ABBV financials, KNSA overview, KNSA financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.